Clinical trials for Zepbound showed that participants achieved an average weight loss of 15% to 22.5%, depending on dosage, with results tracked over 72 weeks under controlled conditions
The platform extracted 340,725 opinions using patented unsupervised AI thematic detection, operating at 98% analysis accuracy on validated language benchmarks
Pharmaceutical companies and researchers are exploring its role in cardiovascular risk reduction, kidney disease management, and other metabolic disorders
A 2026 review found that reports of hair loss have been seen across multiple studies and databases, with the strongest evidence currently linked to semaglutide (Wegovy) and tirzepatide (Mounjaro)
Gastric Electrophysiology Mapping With Simultaneously Validated Patient System Profiling (GEMS) Service, CPT Code 0868T (APC 5723) Effective July 1, 2023, based on a New Technology application received by CMS for the GEMS service, CMS established HCPCS code C9787 ( Gastric electrophysiology mapping with simultaneous patient symptom profiling ) and assigned it to APC 5723 (Level 3 Diagnostic Tests and Related Services) based on a crosswalk to CPT code 0779T
L., Gemmer, C
